Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Hot Stocks
Foghorn Therapeutics appoints Humer as Chief Financial Officer » 07:09
04/16/24
04/16
07:09
04/16/24
07:09
FHTX

Foghorn Therapeutics

$6.36 /

-1.07 (-14.40%)

, VRDN

Viridian Therapeutics

$15.66 /

-0.23 (-1.45%)

Foghorn Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Hot Stocks
Foghorn Therapeutics expects cash runway into first half of 2026 » 07:03
03/07/24
03/07
07:03
03/07/24
07:03
FHTX

Foghorn Therapeutics

$6.71 /

+0.35 (+5.50%)

Cash, cash equivalents…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Foghorn Therapeutics reports FY23 EPS ($2.34), consensus ($2.48) » 07:03
03/07/24
03/07
07:03
03/07/24
07:03
FHTX

Foghorn Therapeutics

$6.71 /

+0.35 (+5.50%)

Reports FY23 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Foghorn Therapeutics, Eli Lilly to present new preclinical data at AACR » 17:03
03/05/24
03/05
17:03
03/05/24
17:03
FHTX

Foghorn Therapeutics

$6.36 /

-0.46 (-6.74%)

, LLY

Eli Lilly

$777.53 /

-14.88 (-1.88%)

Eli Lilly (NYSE: LLY)…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Foghorn Therapeutics says Lilly selects FHD-909 for clinical development » 07:11
02/08/24
02/08
07:11
02/08/24
07:11
FHTX

Foghorn Therapeutics

$3.14 /

-0.045 (-1.42%)

, LLY

Eli Lilly

$725.02 /

+20.05 (+2.84%)

Foghorn Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
Hot Stocks
Foghorn Therapeutics announces strategic objectives for 2024 » 07:43
01/08/24
01/08
07:43
01/08/24
07:43
FHTX

Foghorn Therapeutics

$5.64 /

+0.14 (+2.55%)

"We enter 2024 with…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Prime Medicine appoints Reine as Chief Financial Officer » 08:07
01/05/24
01/05
08:07
01/05/24
08:07
PRME

Prime Medicine

$9.01 /

+0.12 (+1.35%)

, FHTX

Foghorn Therapeutics

$5.50 /

-0.45 (-7.56%)

Prime Medicine (PRME)…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Foghorn Therapeutics CFO Allan Reine to depart » 16:06
01/03/24
01/03
16:06
01/03/24
16:06
FHTX

Foghorn Therapeutics

$5.93 /

-0.55 (-8.49%)

Foghorn Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Foghorn Therapeutics expects cash to fund operations into 1H26 » 07:02
11/02/23
11/02
07:02
11/02/23
07:02
FHTX

Foghorn Therapeutics

$3.69 /

+0.42 (+12.84%)

Cash, cash equivalents,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Foghorn Therapeutics reports Q3 EPS (34c), consensus (75c) » 07:02
11/02/23
11/02
07:02
11/02/23
07:02
FHTX

Foghorn Therapeutics

$3.69 /

+0.42 (+12.84%)

Reports Q3 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Foghorn doses first patient in Phase 1 combination study of FHD-286 » 07:02
08/31/23
08/31
07:02
08/31/23
07:02
FHTX

Foghorn Therapeutics

$7.67 /

+0.04 (+0.52%)

Foghorn Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Foghorn Therapeutics appoints Quintas-Cardama as Chief Medical Officer » 07:44
08/08/23
08/08
07:44
08/08/23
07:44
FHTX

Foghorn Therapeutics

$9.30 /

+0.04 (+0.43%)

Foghorn Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Foghorn Therapeutics reports Q2 EPS (70c), consensus (73c) » 07:06
08/04/23
08/04
07:06
08/04/23
07:06
FHTX

Foghorn Therapeutics

$9.24 /

+0.015 (+0.16%)

Reports Q2 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Foghorn Therapeutics price target lowered to $19 from $21 at Goldman Sachs » 17:46
06/28/23
06/28
17:46
06/28/23
17:46
FHTX

Foghorn Therapeutics

$8.64 /

+0.15 (+1.77%)

Goldman Sachs lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Foghorn FHD-286 discontinuation a net positive, says H.C. Wainwright » 11:33
06/28/23
06/28
11:33
06/28/23
11:33
FHTX

Foghorn Therapeutics

$8.29 /

-0.2 (-2.36%)

H.C. Wainwright analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Foghorn Therapeutics announces data from Phase 1 study of FHD-286 » 07:02
06/28/23
06/28
07:02
06/28/23
07:02
FHTX

Foghorn Therapeutics

$8.37 /

-0.36 (-4.12%)

Foghorn Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Foghorn Therapeutics moving forward after FDA lifts clinical hold, says Wedbush » 13:03
06/05/23
06/05
13:03
06/05/23
13:03
FHTX

Foghorn Therapeutics

$7.24 /

+0.21 (+2.99%)

Wedbush analyst Robert…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Foghorn Therapeutics sees cash runway into 2H25 » 07:18
06/05/23
06/05
07:18
06/05/23
07:18
FHTX

Foghorn Therapeutics

$7.03 /

+0.56 (+8.66%)

"With a focus on…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Foghorn Therapeutics to commence Phase 1 combination study of FHD-286 in Q3 » 07:18
06/05/23
06/05
07:18
06/05/23
07:18
FHTX

Foghorn Therapeutics

$7.03 /

+0.56 (+8.66%)

Foghorn plans to commence…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Foghorn Therapeutics says FDA lifts clinical hold on Phase 1 study of FHD-286 » 07:17
06/05/23
06/05
07:17
06/05/23
07:17
FHTX

Foghorn Therapeutics

$7.03 /

+0.56 (+8.66%)

Foghorn Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Foghorn Therapeutics price target lowered to $20 from $25 at H.C. Wainwright » 06:19
05/09/23
05/09
06:19
05/09/23
06:19
FHTX

Foghorn Therapeutics

$5.43 /

-0.64 (-10.54%)

H.C. Wainwright lowered…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Foghorn Therapeutics reports Q1 EPS (73c), consensus (72c) » 07:07
05/08/23
05/08
07:07
05/08/23
07:07
FHTX

Foghorn Therapeutics

$6.07 /

+0.12 (+2.02%)

Reports Q1 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
C4 Therapeutics price target lowered to $25 from $35 at H.C. Wainwright » 06:12
05/08/23
05/08
06:12
05/08/23
06:12
CCCC

C4 Therapeutics

$3.28 /

+0.055 (+1.71%)

, FHTX

Foghorn Therapeutics

$6.07 /

+0.12 (+2.02%)

H.C. Wainwright analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Foghorn Therapeutics price target lowered to $19 from $20 at BMO Capital » 09:10
04/25/23
04/25
09:10
04/25/23
09:10
FHTX

Foghorn Therapeutics

$6.22 /

-0.62 (-9.06%)

BMO Capital lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Foghorn Therapeutics price target lowered to $15 from $20 at Wedbush » 07:29
04/25/23
04/25
07:29
04/25/23
07:29
FHTX

Foghorn Therapeutics

$6.22 /

-0.62 (-9.06%)

Wedbush lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Foghorn clinical hold does not deter thesis, says H.C. Wainwright » 06:04
04/25/23
04/25
06:04
04/25/23
06:04
FHTX

Foghorn Therapeutics

$6.22 /

-0.62 (-9.06%)

H.C. Wainwright analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a year ago
Hot Stocks
Foghorn Therapeutics pauses enrollment in FHD-609 study due to grade 4 event » 07:04
04/24/23
04/24
07:04
04/24/23
07:04
FHTX

Foghorn Therapeutics

$6.66 /

-0.68 (-9.26%)

Foghorn Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.